Catena Biosciences

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Tubulis

This deep-tech company develops antibody-drug conjugates to treat patients with solid tumours.

Cartography Biosciences

This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

AI Proteins

This deep-tech company designs engineered miniprotein biologics for patients and pharmaceutical partners using artificial intelligence and synthetic biology.

ParcelBio

This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.

Cristal Therapeutics

This deep-tech company develops click chemistry reagents and nanoparticle delivery platforms for pharmaceutical and diagnostic partners in the life sciences industry.